RELMADA THERAPEUTICS, INC. (RLMD) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Relmada Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Relmada Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$583 M, a 19.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$583 M -$94.3 M -19.3% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$561 M -$98.8 M -21.4% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$536 M -$112 M -26.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$514 M -$129 M -33.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$488 M -$144 M -41.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$462 M -$157 M -51.5% Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$424 M -$153 M -56.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$385 M -$157 M -68.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$345 M -$143 M -71.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$305 M -$126 M -70.1% Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$271 M -$112 M -70.7% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$228 M -$86.4 M -61% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$202 M -$71 M -54.4% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 -$179 M -$59.5 M -49.6% Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$159 M -$43.2 M -37.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$142 M -$30 M -26.9% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 -$131 M -$23 M -21.4% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 -$120 M -$15 M -14.3% Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$115 M -$17.6 M -18% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$112 M -$17.3 M -18.4% Jun 30, 2019 10-K 2021-03-24
Q1 2019 -$108 M -$16.5 M -18.2% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 -$105 M -$17.1 M -19.4% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 -$97.7 M -$11.4 M -13.2% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 -$94.3 M -$8.96 M -10.5% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$91 M -$7.24 M -8.65% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 -$87.8 M -$6.02 M -7.37% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 -$86.4 M -$5.63 M -6.97% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 -$85.4 M -$6.29 M -7.95% Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$83.7 M -$7.97 M -10.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$81.8 M -$7.85 M -10.6% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 -$80.7 M -$9.28 M -13% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$79.1 M -$2.97 M -3.91% Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$75.8 M +$6.39 M +7.77% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$73.9 M +$5.78 M +7.25% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 -$71.5 M Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$76.1 M -$20.8 M -37.6% Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$82.2 M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 -$79.7 M Dec 31, 2014 10-Q 2015-02-13
Q2 2014 -$55.3 M Jun 30, 2014 10-K 2015-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.